Cite
Novel Alaninamide Derivatives with Drug-like Potential for Development as Antiseizure and Antinociceptive Therapies─In Vitro and In Vivo Characterization.
MLA
Jakubiec, Marcin, et al. “Novel Alaninamide Derivatives with Drug-like Potential for Development as Antiseizure and Antinociceptive Therapies─In Vitro and In Vivo Characterization.” ACS Chemical Neuroscience, vol. 15, no. 11, June 2024, pp. 2198–222. EBSCOhost, https://doi.org/10.1021/acschemneuro.4c00013.
APA
Jakubiec, M., Abram, M., Zagaja, M., Andres-Mach, M., Szala-Rycaj, J., Latacz, G., Honkisz-Orzechowska, E., Mogilski, S., Kubacka, M., Szafarz, M., Pociecha, K., Przejczowska-Pomierny, K., Wyska, E., Socała, K., Nieoczym, D., Szulczyk, B., Wlaź, P., Metcalf, C. S., Wilcox, K., … Kamiński, K. (2024). Novel Alaninamide Derivatives with Drug-like Potential for Development as Antiseizure and Antinociceptive Therapies─In Vitro and In Vivo Characterization. ACS Chemical Neuroscience, 15(11), 2198–2222. https://doi.org/10.1021/acschemneuro.4c00013
Chicago
Jakubiec, Marcin, Michał Abram, Mirosław Zagaja, Marta Andres-Mach, Joanna Szala-Rycaj, Gniewomir Latacz, Ewelina Honkisz-Orzechowska, et al. 2024. “Novel Alaninamide Derivatives with Drug-like Potential for Development as Antiseizure and Antinociceptive Therapies─In Vitro and In Vivo Characterization.” ACS Chemical Neuroscience 15 (11): 2198–2222. doi:10.1021/acschemneuro.4c00013.